INO ▲ +176.6% - Inovio Pharmaceuticals, Inc.
$INO INO - INOVIO Announces FDA Accelerated Approval of VOCERYQ™, an Immunotherapy to Reduce the Frequency of Surgery in Adults with Recurrent Respiratory Papillomatosis (RRP)
30-OCT-2026 06:02 PM ET
Share this post
More filings for $INO
INO ▲ +198.7% - Inovio Pharmaceuticals, Inc.Oct 30, 2026INO ▲ +181.8% - Inovio Pharmaceuticals, Inc.Oct 30, 2026INO ▼ -2.6% - Inovio Pharmaceuticals, Inc.Oct 30, 2026INO ▲ +13.0% - Inovio Pharmaceuticals, Inc.Oct 20, 2026INO ▲ +3.1% - Inovio Pharmaceuticals, Inc.Sep 1, 2026INO - Inovio Pharmaceuticals, Inc. - SEC Filing Update (12-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 12, 2026
View full $INO filing history →💬 Comments
Loading comments…
Leave a comment